...chemistry lead optimization for an undisclosed Synaptica program. The companies also will generate compounds for Synaptica... ...for neurological diseases. Maybridge will receive chemistry- and synthesis-related payments. Maybridge plc , Cornwall, U.K. Synaptica Ltd....
...used to develop third generation therapeutics for Alzheimer's disease and other neurological disorders. In exchange, Synaptica... ...SAC's compounds for use in its own neurodegeneration program. Sanochemia Pharmazeutika AG (NMarkt:SAC), Vienna, Austria Synaptica Ltd....
Synaptica Ltd. , Oxford, U.K. Business: Neurological Hired: Steven Butcher as research director and a director, formerly VP of science at Gemini Genomics plc
WIR Staff...
...chemistry lead optimization for an undisclosed Synaptica program. The companies also will generate compounds for Synaptica... ...for neurological diseases. Maybridge will receive chemistry- and synthesis-related payments. Maybridge plc , Cornwall, U.K. Synaptica Ltd....
...used to develop third generation therapeutics for Alzheimer's disease and other neurological disorders. In exchange, Synaptica... ...SAC's compounds for use in its own neurodegeneration program. Sanochemia Pharmazeutika AG (NMarkt:SAC), Vienna, Austria Synaptica Ltd....
Synaptica Ltd. , Oxford, U.K. Business: Neurological Hired: Steven Butcher as research director and a director, formerly VP of science at Gemini Genomics plc
WIR Staff...